Kazia Therapeutics Limited (NASDAQ: KZIA) shares up about 15% on Friday after the Company announced that the United States Food and Drug Administration (FDA) has awarded Orphan Drug Designation (ODD) to Kazia's paxalisib for the treatment of atypical rhabdoid /...
Sony group Corporation (NYSE: SONY) and Honda Motor Co., Ltd. (NYSE: HMC) reported signature on a joint venture agreement to establish Sony Honda Mobility Inc....
Revlon (NYSE: REV), a multinational cosmetics company, filed for Chapter 11 bankruptcy protection on Wednesday as it deals with continuous supply chain disruptions and its...
Sidus Space, Inc. (NASDAQ: SIDU) announced yesterday that it is part of the Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity (xEVAS) services...
Sidus Space, Inc. (NASDAQ: SIDU) shares skyrocketed more than 100% on Wednesday after the Company announced that it is part of the Collins Aerospace team...
Amazon.com, Inc. (NASDAQ: AMZN) has announced two joint lawsuits against a social media influencer and eight businesses for advertising promoting and facilitating the sale of...
Wayfair (NYSE: W) has released its inaugural Corporate Responsibility Report. “While we are at the beginning of our journey, we are motivated by our desire...
Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) announced yesterday after the market close that it has reached an agreement with Philip Morris Products S.A. to...
Continental Resources, Inc. (NYSE: CLR) shares jumped more than 13% Tuesday after the Company announced that its board of directors has received a non-binding proposal...
Oracle Corporation (NYSE: ORCL) has reported fiscal 2022 Q4 financial results. Quarterly revenues rose 5% year over year. Cloud services and license support revenues had...
FedEx Corporation (NYSE: FDX) has reported a series of planned business and corporate governance actions that work towards the Company’s efforts to drive long term...
Signature Bank (NASDAQ: SBNY) has reported appointment of five private client banking teams through the metropolitan New York area, as well as a group director...
Day One Biopharmaceuticals (Nasdaq: DAWN) today announced positive initial data from pivotal FIREFLY-1 trial of Tovorafenib. Shares of Day One Biopharmaceuticals (Nasdaq: DAWN) opened 125%...
